DMAC
DiaMedica Therapeutics Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:51 PM EDT
8.24USD-1.317%(-0.11)335,683
Loading…
Loading…
444.35M
Healthcare
Biotechnology
HQ
Minneapolis, MN, USA
Previous Close
$8.35
Beta
1.51
52-Week High
$10.42 2025-12-10
52-Week Low
$5.25 2026-06-11
SMA 50
$6.89
SMA 200
$7.10
Avg. Vol 10D
259,666
Avg. Vol 30D
184,597
Avg. Vol 90D
194,516
Relative Vol
1.82
53.93M
27.07M
50.19%
5,486,848
20.27%
36.67
63%/37%
51.24%
36.55%
0.5700%
350,000
13
3,964
11,403
Nov 11, 2026 (37d)
DMAC Profile
diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.
DMAC Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.32 | 2026-09-28 | -0.96% | -1.129 |
| 1M | 6.75 | 2026-09-04 | +22.07% | 1.570 |
| 3M | 8.01 | 2026-07-06 | +2.87% | 1.133 |
| 6M | 6.62 | 2026-04-06 | +24.47% | 1.128 |
| 1Y | 7.07 | 2025-10-03 | +16.55% | 1.510 |
| 2Y | 4.36 | 2024-10-04 | +88.99% | — |
| 5Y | 4.02 | 2021-10-04 | +104.97% | 0.874 |
DMAC Stock Summary
DiaMedica Therapeutics Inc. Common Stock (NASDAQ:DMAC) stock price today is $8.24, and today's volume is 335,683. DMAC is down 1.317% today. The 30 day average volume is 184,597. DMAC market cap is $444.35M with 53.93M shares outstanding.